Panel: Drug Sponsors Need to Record More Patient-Centered Data

Drug Industry Daily
A A
Drug sponsors should find a more comprehensive way of recording and integrating patient outcomes data into their efficacy analyses, says a top FDA official who notes the lack of such data often presents a roadblock to making regulatory decisions.

To View This Article:

Login

Subscribe To Drug Industry Daily